Delhi HC stays FSSAI action against Dabur’s ‘100%’ food-product claims
The Delhi High Court has stayed FSSAI’s direction asking Dabur to halt food products carrying “100%” claims, including honey, oils, ghee, coconut water and coconut milk. The court cited a prima facie case and absence of a prior hearing; the next hearing is due in two weeks.
What happened
Dabur India · Delhi High Court stayed FSSAI’s order requiring Dabur to halt food products carrying “100%” claims, finding a prima facie case and lack of prior
Key facts
- 100%
- 2018
- two weeks
Why this matters
The ruling highlights that claim-heavy food brands carry material regulatory diligence risk, making evidence trails, label-rights reviews and FSSAI compliance history central to valuation and deal terms.
What to watch
- Whether the next Delhi High Court hearing extends, modifies or vacates the stay.
- FSSAI's underlying rationale: whether it challenges the truth of Dabur's formulations, the absence of qualifiers, or the broad consumer interpretation of '100%'.
- Any requirement for Dabur to submit testing, traceability or category-specific substantiation.
- New FSSAI notices or enforcement action against comparable claims by other packaged-food brands.
- Retailer or marketplace requests for indemnities, revised labels or supporting documentation.
- Evidence of accelerated discounting or channel-level returns if a relabelling directive is reinstated.
- Dabur will preserve current packaging and compile substantiation dossiers for honey, edible oils, ghee, coconut water and coconut milk claims.
- FSSAI is likely to submit its scientific and legal basis for treating '100%' as misleading, while seeking to cure the prior-hearing procedural gap.
- Competing FMCG companies will review absolute claims such as 'pure', 'natural', '100%', 'chemical-free' and 'no added' for vulnerability and may delay voluntary pack changes pending the ruling.
- Modern trade, e-commerce marketplaces and distributors are likely to retain existing Dabur inventory rather than halt listings while the stay remains active.
- Advertising and legal teams across FMCG will increase use of qualified claims and retain laboratory, sourcing and formulation evidence for future challenges.